Methotrexate therapy in systemic-onset juvenile rheumatoid arthritis in Saudi Arabia: a retrospective analysis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 9586680)

Published in Clin Rheumatol on January 01, 1998

Authors

W al-Sewairy1, A al-Mazyed, al-Dalaan, S al-Balaa, S Bahabri

Author Affiliations

1: Department of Pediatrics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

Articles cited by this

Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum (1994) 3.15

Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr (1990) 2.88

Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N Engl J Med (1992) 2.62

A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum (1986) 2.56

Heberden Oration, 1977. Chronic arthritis in childhood. Ann Rheum Dis (1978) 2.55

Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. Arthritis Rheum (1992) 1.51

Juvenile rheumatoid arthritis: a review. Pediatrics (1972) 1.46

Severe flare of rheumatoid arthritis after discontinuation of long-term methotrexate therapy. Double-blind study. Am J Med (1987) 1.11

Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis. Arthritis Rheum (1989) 1.03

Methotrexate therapy in juvenile rheumatoid arthritis: a retrospective study. Arthritis Rheum (1986) 0.97

Evaluation of methotrexate in the treatment of juvenile chronic arthritis according to the subtype. Clin Exp Rheumatol (1991) 0.93

Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis. J Pediatr (1992) 0.90

Prognosis of juvenile rheumatoid arthritis. Arthritis Rheum (1977) 0.89

Slow-acting antirheumatic drugs in chronic arthritis of childhood. Semin Arthritis Rheum (1988) 0.88

Low-dose methotrexate in systemic onset juvenile chronic arthritis. Clin Exp Rheumatol (1990) 0.87

Current status of the medical treatment of children with juvenile rheumatoid arthritis. Rheum Dis Clin North Am (1991) 0.87

Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single center double blind comparative study. J Rheumatol (1986) 0.87

Factors associated with response to methotrexate in systemic-onset juvenile chronic arthritis. Acta Paediatr (1994) 0.86

Predicting remission in juvenile rheumatoid arthritis with methotrexate treatment. J Rheumatol (1993) 0.86

High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis. Clin Exp Rheumatol (1995) 0.86

Long-term methotrexate therapy for rheumatoid arthritis. Semin Arthritis Rheum (1991) 0.85

Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis. J Rheumatol (1992) 0.84

Radiologic features of systemic onset juvenile rheumatoid arthritis. J Rheumatol (1995) 0.81

Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis. J Pediatr (1992) 0.81

Evaluation of D-penicillamine in juvenile chronic arthritis. A double-blind, multicenter study. Arthritis Rheum (1985) 0.78

Gold therapy in the management of juvenile rheumatoid arthritis. Arthritis Rheum (1980) 0.77

Hepatic fibrosis with the use of methotrexate for juvenile rheumatoid arthritis. J Rheumatol (1990) 0.77

Slow-acting antirheumatic drug use in systemic onset juvenile chronic arthritis. Pediatrics (1986) 0.77

Frequency of relapse after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis. J Rheumatol (1995) 0.76

Prognosis in juvenile rheumatoid arthritis with systemic onset. A follow-up study. Scand J Rheumatol (1983) 0.76

Articles by these authors

Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet (2001) 2.81

Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol (1998) 1.29

Behçet's disease in Saudi Arabia. J Rheumatol (1994) 1.20

Infantile systemic hyalinosis: a fatal disorder commonly diagnosed among Arabs. Clin Exp Rheumatol (2005) 1.14

Hemophagocytosis complicating Kawasaki disease. Pediatr Hematol Oncol (2000) 1.08

New form of idiopathic osteolysis: nodulosis, arthropathy and osteolysis (NAO) syndrome. Am J Med Genet (2000) 1.01

The prevalence of rheumatoid arthritis in the Qassim region of Saudi Arabia. Ann Saudi Med (1998) 0.88

Association of anti-cardiolipin antibodies with vascular thrombosis and neurological manifestation of Behçets disease. Clin Rheumatol (1993) 0.88

Enhanced interleukin 8 secretion in circulation of patients with Behçet's disease. J Rheumatol (1995) 0.86

Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate. Clin Rheumatol (2000) 0.86

Coexistent linear scleroderma and juvenile systemic lupus erythematosus. Pediatr Dermatol (2001) 0.85

A mixed Th1/Th2 cell cytokine response predominates in systemic onset juvenile rheumatoid arthritis: immunoregulatory IL-10 function. Clin Immunol Immunopathol (1998) 0.84

Spinal cord involvement in pediatric systemic lupus erythematosus: case report and literature review. Clin Exp Rheumatol (1999) 0.82

Radiological features in congenital camptodactyly, familial arthropathy and coxa vara syndrome. Pediatr Radiol (1994) 0.80

Juvenile dermatomyositis: clinical profile and disease course in 25 patients. Clin Exp Rheumatol (1999) 0.80

Efficacy of recombinant human growth hormone in children with juvenile rheumatoid arthritis and growth failure. J Pediatr Endocrinol Metab (2000) 0.78

Juvenile Behçet's disease in Arab children. Clin Exp Rheumatol (1996) 0.78

Pseudotumor cerebri and leukoencephalopathy in childhood lupus. Lupus (1999) 0.77

Pattern of adult onset of polymyositis and dermatomyositis and association with malignancy. Ann Saudi Med (1993) 0.75

Hypergammaglobulinaemic purpura associated with IgG subclass imbalance and recurrent infection. Clin Rheumatol (2000) 0.75

Abnormalities of T cell subsets in Behcet disease. Ann Saudi Med (1993) 0.75

Atypical Kawasaki disease with coronary artery involvement. Ann Saudi Med (2007) 0.75

Hypertrophic osteoarthropathy caused by lipoid pneumonia. Pediatr Radiol (1995) 0.75

Budd-Chiari syndrome in association with Behçet's disease. J Rheumatol (1991) 0.75

Interstitial pneumonitis and air leakage in juvenile dermatomyositis. Rheumatology (Oxford) (2001) 0.75

Infections associated with juvenile systemic lupus erythematosus. Clin Exp Rheumatol (2002) 0.75